Skip to main content
Premium Trial:

Request an Annual Quote

LifeSensors Licenses Proteomics Tech from Spanish Center

NEW YORK (GenomeWeb News) – Proteomics technologies company LifeSensors has licensed technology from Spain's CICbioGUNE research center for use in purifying ubiquitylated proteins that are unstable and difficult to characterize.

LifeSensors said on Tuesday that it signed a worldwide, exclusive license for the Tandem-repeated Ubiquitin Binding Entities (TUBEs) technology, which was developed at CICbioGUNE's proteomics unit.

These TUBEs proteins may be used to capture ubiquitin pathway proteins, which "play key roles in numerous diseases from neurodegeneration to cancer," the company said. The technology can be used to purify ubiquitylated proteins from cells, tissues, and organs, according to LifeSensors.

"We have successfully used the TUBEs to identify novel proteins modified by ubiquitin and protect ubiquitylated proteins from degradation, all without the need for inhibitors or overexpression techniques," CICbioGUNE's Group Leader of Proteomics Manuel Rodriguez said in a statement.

Financial terms of the agreement were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.